Home › Funds › Rosalind Advisors, Inc. › REPL
Rosalind Advisors, Inc. position in REPL
REPLIMUNE GROUP INC · Health Care
Rosalind Advisors, Inc. reported holding 1,000,000 shares of REPL (REPLIMUNE GROUP INC) in its Q3 2026 13F filing — a position valued at US$13.2M, representing 5.41% of its reported portfolio and ranking #5 among its reported holdings. Rosalind Advisors, Inc. has disclosed REPL holdings in 6 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rosalind Advisors, Inc.'s REPL position evolved
Rosalind Advisors, Inc. first disclosed a stake in REPL in Q4 2024 at 260,000 shares (US$3.1M). The position peaked in Q3 2026 at 1,000,000 shares, worth US$13.2M. Across 6 filings, Rosalind Advisors, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,000,000 shares valued at US$13.2M. Notable position changes include a 227% increase in Q1 2025 (shares fell 5% over the following quarter), a 73% trim in Q2 2025 (shares fell 55% over the following quarter), a 121% increase in Q3 2025 (shares rose 132% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 260.00K | $3.15M | New |
| Q1 2025 | 850.00K | $8.29M | Add |
| Q2 2025 | 231.80K | $515.65K | Reduce |
| Q3 2025 | 511.40K | $183.10K | Add |
| Q1 2026 | 1.28M | $2.75M | New |
| Q3 2026 | 1.00M | $13.24M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REPL and 13F data
REPL (REPLIMUNE GROUP INC) is a Health Care company. 45 other funds we track also report a position in REPL — the largest reported positions include BAKER BROS. ADVISORS LP (US$122.3M), RTW INVESTMENTS, LP (US$112.4M), Ridgeback Capital Investments L.P. (US$80.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REPL
- BAKER BROS. ADVISORS LP 11.05M sh · $122.27M · Q2 2026
- RTW INVESTMENTS, LP 8.49M sh · $112.43M · Q3 2026
- Ridgeback Capital Investments L.P. 7.31M sh · $80.93M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.39M sh · $48.60M · Q2 2026
- Boxer Capital Management, LLC 3.98M sh · $44.09M · Q2 2026
- FCPM III SERVICES B.V. 1.72M sh · $22.78M · Q3 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 1.60M sh · $21.23M · Q3 2026
- Logos Global Management LP 1.50M sh · $19.86M · Q3 2026
- Opaleye Management Inc. 1.38M sh · $15.33M · Q2 2026
- Sio Capital Management, LLC 865.33K sh · $11.46M · Q3 2026
- Eagle Health Investments LP 724.79K sh · $9.60M · Q3 2026
More on Rosalind Advisors, Inc.
FAQ
How long has Rosalind Advisors, Inc. held REPL?
Rosalind Advisors, Inc. has disclosed REPL holdings in 6 of the last 8 reported quarters, going back to Q4 2024.
What is Rosalind Advisors, Inc.'s current position in REPL?
As of Q3 2026, Rosalind Advisors, Inc. holds 1.00M shares of REPL (REPLIMUNE GROUP INC), valued at $13.24M, representing 5.41% of its reported portfolio and ranking #5.
Has Rosalind Advisors, Inc. been buying or selling REPL?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. newly opened its position in REPL. The position peaked in Q3 2026 at 1.00M shares.
Which other funds hold REPL?
Other major institutional holders of REPL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Ridgeback Capital Investments L.P., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.